Issue 7, 2021

Recent advances in the development of covalent inhibitors

Abstract

The use of covalent inhibitors in the field of drug discovery has attracted considerable attention in the 2000s. As a result, more than 50 covalent drugs are currently on the market, and numerous covalent drug candidates are now under development. Therefore, interest in covalent drugs is expected to continue in the future. The purpose of this focused review is to provide an understanding of the development of covalent inhibitors by describing their inherent characteristics, possibilities, and limitations based on their mechanistic differences from noncovalent inhibitors. We also introduce the latest covalent warheads that can be applied to the development of potential covalent inhibitors.

Graphical abstract: Recent advances in the development of covalent inhibitors

Article information

Article type
Review Article
Submitted
03 mrt 2021
Accepted
23 apr 2021
First published
04 mei 2021

RSC Med. Chem., 2021,12, 1037-1045

Recent advances in the development of covalent inhibitors

H. Kim, Y. S. Hwang, M. Kim and S. B. Park, RSC Med. Chem., 2021, 12, 1037 DOI: 10.1039/D1MD00068C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements